tiprankstipranks
Denali Therapeutics (DNLI)
NASDAQ:DNLI

Denali Therapeutics (DNLI) Stock Investors

596 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DNLI
On average, investors allocate 3.11% of their portfolios to DNLI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding DNLI

0.2%
Last 7
Days
0.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DNLI, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

DNLI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.00%
$23.35
Increased
2.21%
$19.93
Increased
0.03%
$23.33
Increased
1.37%
$20.52
Opened
1.64%
$17.89
Opened
2.50%
$18.55
Increased
0.32%
$21.78
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in DNLI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

DNLI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.23%
-0.90%
+1.25%
86.44B
Healthcare
DraftKings
5.81%
-1.48%
-2.00%
32.41B
Consumer Cyclical
Merck & Company
3.90%
-0.58%
+3.35%
318.55B
Healthcare
GE Aerospace
5.19%
-0.16%
+1.09%
174.18B
Industrials
Trade Desk
4.67%
-1.31%
+0.13%
46.96B
Technology
Delta Air Lines
5.26%
-0.38%
+2.22%
29.33B
Industrials
Block
4.24%
-1.18%
-0.17%
42.02B
Technology
ChargePoint Holdings
4.17%
-1.00%
-2.43%
833.60M
Consumer Cyclical
Zscaler
3.82%
-1.05%
+1.72%
28.50B
Technology
Enphase Energy
4.97%
-1.43%
-1.76%
14.35B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

DNLI Investor Analysis

DNLI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.7%
of DNLI holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
DNLI investors between 35–55

Between 35–55

3.4%
Last 30 days
Holdings Change
53.3%
of DNLI holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
DNLI investors over 55

Over 55

6.2%
Last 30 days
Holdings Change
40.0%
of DNLI holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of DNLI stock investors
See who invests in DNLI according to age group and performance.

FAQ

How many retail Investors hold DNLI?
<0.1% of TipRanks' retail investors hold DNLI in their portfolios.
    What is DNLI Investor Sentiment?
    DNLI’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of DNLI in the last 7 days?
      ▼ 0.2% of TipRanks' retail investors changed their holding of DNLI in the last 7 days.
        What percentage of retail investors changed their holding of DNLI in the last 30 days?
        ▲ 0.9% of TipRanks' retail investors changed their holding of DNLI in the last 30 days.
          What is the average age of retail investors who hold DNLI?
          The average age of DNLI Holders is between 35–55.
            What other stocks have DNLI investors also bought?
            DNLI Investors also bought BMY, DKNG, MRK, GE, TTD, DAL, SQ, CHPT, ZS, ENPH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              CYTKCytokinetics
              DHRDanaher
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis